| JNJ-38877605 |
|
| (CAS 943540-75-8) |
 |
| Description： |
JNJ-38877605 is an ATP-competitive inhibitor of c-Met with IC50 of 4 nM, 600-fold selective for c-Met than 200 other tyrosine and serine-threonine kinases.
in vivo: In mice bearing established GTL16 xenografts, JNJ-38877605, dosed orally with 40 mg/kg/day for 72 hours, results in a statistically significant decrease in the plasma levels of human IL-8 (from 0.150 ng/mL to 0.050 ng/mL) and GROα (from 0.080 ng/mL to 0.030 ng/mL). While concentrations of uPAR in the blood become reduced to more than 50% at the same dose .
|
| Product No. |
KT00469 |
| Product Name |
JNJ-38877605 |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
943540-75-8 |
| Molecular Formula |
C19H13F2N7 |
| Formula Weight |
377.35 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
AMG-208
BMS 777607
Crizotinib
E-7050
EMD-1214063
Foretinib
INCB28060
LY2801653
MGCD-265
|
|
